Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
- Type
- Retraction
- Notice date
- 1/16/2026 0:00
- Journal
- The Journal of Clinical Investigation (JCI)
- Publisher
- American Society for Clinical Investigation
- Notice DOI
- 10.1172/jci202473
- Original paper DOI
- 10.1172/jci146832